Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Macitentan. Macitentan is a dual endothelin receptor antagonist (ERA) used in the treatment of pulmonary arterial hypertension (PAH) to improve exercise capacity and delay disease progression. It works by blocking both ETA and ETB receptors, thereby reducing endothelin-mediated vasoconstriction and vascular remodeling in the pulmonary arteries. Administered orally once daily, Macitentan offers sustained receptor binding and favorable pharmacokinetics compared to older ERAs. It helps lower pulmonary vascular resistance, improve cardiac output, and enhance quality of life in PAH patients. The drug is metabolized by CYP3A4, producing an active metabolite that contributes to its long-lasting effects. Common side effects include headache, anemia, nasal congestion, and elevated liver enzymes. Macitentan is valued for its efficacy, safety, and improved tolerability in long-term PAH management. Buy high quality Macitentan from Omsynth Lifesciences.
